PNA antisense oligonucleotides (Santaris)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePNA antisense oligonucleotides (Santaris)

Drug Alias NamePNA antisense oligonucleotides (Pantheco)PNAbioticspeptide nucleic acid antisense oligonucleotides (Santaris)peptide nucleic acid antisense oligonucleotides (Pantheco)PA-2120 +[9]

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAntisense oligonucleotide inhibitorsProtein synthesis inhibitors

TargetsUpdating

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoche Innovation Center Copenhagen A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoche Innovation Center Copenhagen A/S

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A